Results of electromyostimulation therapy in obstructive sleep apnea
- PMID: 18782139
- DOI: 10.1111/j.1525-1594.2008.00618.x
Results of electromyostimulation therapy in obstructive sleep apnea
Abstract
Innovative muscle stimulation techniques have become alternatives for therapy of obstructive sleep apnea syndrome breathing disorders. In group I, an individually shaped mouth floor electrode (IME) and in group II, an individually adaptable multi-point electrode (MPE) on a silicone carrier has been used for electromyostimulation (EMS) therapy in patients with obstructive sleep apnea. The enoral-cutaneous EMS was carried out with the low-frequency stimulation apparatus I-pulse over a period of 8 weeks, two times daily for 30 min during daytime hours only. In group III, the patients used EMS therapy for half a year continuously. Before and after stimulation treatment, three-dimensional volumetric sonographical measurement of the geniohyoid muscle was carried out. All patients (n = 14) totally applied the EMS therapy. Under IME and MPE application after 4 weeks of EMS therapy, a median volume increase of 19.6% (minimum 9.7%, maximum 27.9%) was registered, the median after 8 weeks IME was 27.6% and in MPE 24.0%). No significant difference (analysis of variance type: P > 0.05) between electrodes could be found. In all groups, a reduction of the muscle length of 4.7% was proved. In groups I and II after 26 weeks, the volume was near baseline before stimulation (+4.3%). In the third group, the increase of volume persisted (+29.4%) over the observation period of 12-26 weeks. Opposed to established stimulation techniques, a threefold effectiveness enhancement could be verified by using both individually adaptable electrodes. The EMS therapy should be carried out as continuous long-term therapy or as interval therapy.
Similar articles
-
[Electrical stimulation of the genioglossus to improve pharyngeal patency in obstructive sleep apnea: comparison of results obtained during sleep and anesthesia].Harefuah. 2009 May;148(5):315-9, 350, 349. Harefuah. 2009. PMID: 19630362 Hebrew.
-
Pharmacotherapy of obstructive sleep apnea.Ther Adv Respir Dis. 2008 Dec;2(6):375-86. doi: 10.1177/1753465808098225. Ther Adv Respir Dis. 2008. PMID: 19124383 Review.
-
The effect of multilevel upper airway surgery on continuous positive airway pressure therapy in obstructive sleep apnea/hypopnea syndrome.Laryngoscope. 2009 Jan;119(1):193-6. doi: 10.1002/lary.20021. Laryngoscope. 2009. PMID: 19117285
-
Pediatric sleep apnea: early onset of the 'syndrome'?Sleep Med Rev. 2009 Apr;13(2):111-22. doi: 10.1016/j.smrv.2008.07.001. Epub 2008 Dec 5. Sleep Med Rev. 2009. PMID: 19058983 Review.
-
Mandibular advancement for obstructive sleep apnea: dose effect on apnea, long-term use and tolerance.Respiration. 2008;76(4):386-92. doi: 10.1159/000156861. Epub 2008 Sep 17. Respiration. 2008. PMID: 18797161
Cited by
-
Electrical stimulation therapy improves sleep respiratory parameters in obstructive sleep apnea syndrome: a meta-analysis.J Huazhong Univ Sci Technolog Med Sci. 2013 Oct;33(5):623-627. doi: 10.1007/s11596-013-1169-9. Epub 2013 Oct 20. J Huazhong Univ Sci Technolog Med Sci. 2013. PMID: 24142709
-
Potential therapeutic targets in obstructive sleep apnoea.Expert Opin Ther Targets. 2009 Jul;13(7):795-809. doi: 10.1517/14728220903005608. Expert Opin Ther Targets. 2009. PMID: 19530985 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical